Indio (111in) Dtpa Curium Pharma Spain

Indium-111 pentetate, the active ingredient in Indio, is a radiopharmaceutical presented as a kit for radiolabeling (intrathecal diagnostic kit) for intrathecal use. It enables imaging of cerebrospinal fluid pathways and detection of CSF leaks in patients undergoing diagnostic evaluation.

GNH USA supplies Indio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, diagnostic centres and clinics worldwide.

Indio is used in diagnostic imaging of the cerebrospinal fluid system and related conditions. - Cerebrospinal fluid (CSF) flow studies: assessment of CSF circulation patterns and dynamics. - Detection of CSF leaks: identification of spinal or cranial cerebrospinal fluid leaks. - Evaluation of ventricular shunt patency: verification that implanted shunts are functioning correctly.

Adverse reactions may occur following intrathecal administration of Indio.

Common Side Effects: - Headache: mild to moderate pain at the injection site. - Nausea or vomiting: transient gastrointestinal discomfort. - Transient fever: low‑grade temperature elevation. - Back pain: soreness at lumbar puncture site. - Mild dizziness or light‑headedness.

Serious or Rare Side Effects: - Allergic reaction: rash, urticaria, or anaphylaxis. - Meningitis: signs of infection after lumbar puncture. - Radiation‑induced myelopathy: rare neurologic deficit. - Severe hypotension: marked drop in blood pressure. - Seizures: uncommon neurologic event.

When using Indio, clinicians should observe specific safety measures. - Patient selection: ensure indication is appropriate and contraindications are absent. - Lumbar puncture technique: perform under sterile conditions to minimize infection risk. - Radiation safety: limit exposure to staff and patient according to local regulations. - Monitoring: observe patients for immediate adverse reactions post‑administration. - Storage: keep at ambient temperature: store in original packaging, protect from light and moisture.

Potential drug interactions should be reviewed before administering Indio.

Major Interactions (Avoid): - Concurrent intrathecal chemotherapy agents: increased neurotoxicity risk. - Other intrathecal radiopharmaceuticals: cumulative radiation exposure.

Moderate Interactions (Monitor Closely): - Intravenous contrast media: may alter imaging interpretation. - Anticoagulants or antiplatelet drugs: heightened bleeding risk from lumbar puncture. - Systemic steroids: possible modification of CSF distribution. - Beta‑blockers: may affect hemodynamic response during procedure.